Logo image of OZ

BELPOINTE PREP LLC (OZ) Stock Fundamental Analysis

NYSEARCA:OZ - NYSE Arca - US0806941029 - Common Stock - Currency: USD

63.9  -0.08 (-0.12%)

Fundamental Rating

1

Taking everything into account, OZ scores 1 out of 10 in our fundamental rating. OZ was compared to 64 industry peers in the Real Estate Management & Development industry. Both the profitability and financial health of OZ have multiple concerns. OZ is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

OZ had negative earnings in the past year.
In the past year OZ has reported a negative cash flow from operations.
OZ Yearly Net Income VS EBIT VS OCF VS FCFOZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 -50M -100M -150M

1.2 Ratios

Looking at the Return On Assets, with a value of -4.00%, OZ is in line with its industry, outperforming 43.33% of the companies in the same industry.
Looking at the Return On Equity, with a value of -6.42%, OZ is in line with its industry, outperforming 48.33% of the companies in the same industry.
Industry RankSector Rank
ROA -4%
ROE -6.42%
ROIC N/A
ROA(3y)-2.28%
ROA(5y)N/A
ROE(3y)-2.58%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
OZ Yearly ROA, ROE, ROICOZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 20 40 60 80 100

1.3 Margins

OZ does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
OZ Yearly Profit, Operating, Gross MarginsOZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 -200 -400 -600

1

2. Health

2.1 Basic Checks

OZ does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, OZ has more shares outstanding
The debt/assets ratio for OZ is higher compared to a year ago.
OZ Yearly Shares OutstandingOZ Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 1M 2M 3M
OZ Yearly Total Debt VS Total AssetsOZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 100M 200M 300M

2.2 Solvency

OZ has a Debt/Equity ratio of 0.48. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.48, OZ perfoms like the industry average, outperforming 48.33% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC8.82%
OZ Yearly LT Debt VS Equity VS FCFOZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 100M -100M 200M 300M

2.3 Liquidity

A Current Ratio of 0.75 indicates that OZ may have some problems paying its short term obligations.
OZ has a worse Current ratio (0.75) than 78.33% of its industry peers.
OZ has a Quick Ratio of 0.75. This is a bad value and indicates that OZ is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.75, OZ is doing worse than 73.33% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.75
Quick Ratio 0.75
OZ Yearly Current Assets VS Current LiabilitesOZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 50M 100M 150M 200M

2

3. Growth

3.1 Past

OZ shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -49.22%.
Looking at the last year, OZ shows a decrease in Revenue. The Revenue has decreased by -2.92% in the last year.
The Revenue has been growing by 181.54% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-49.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-107.36%
Revenue 1Y (TTM)-2.92%
Revenue growth 3Y181.54%
Revenue growth 5YN/A
Sales Q2Q%83.76%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
OZ Yearly Revenue VS EstimatesOZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 500K 1M 1.5M 2M
OZ Yearly EPS VS EstimatesOZ Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for OZ. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OZ Price Earnings VS Forward Price EarningsOZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OZ Per share dataOZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 -40 60 80

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for OZ!.
Industry RankSector Rank
Dividend Yield N/A

BELPOINTE PREP LLC

NYSEARCA:OZ (2/21/2025, 8:04:02 PM)

63.9

-0.08 (-0.12%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners34.9%
Inst Owner Change5.99%
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap239.63M
Analysts0
Price TargetN/A
Short Float %1.77%
Short Ratio6.27
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 114.54
P/FCF N/A
P/OCF N/A
P/B 0.78
P/tB 0.78
EV/EBITDA N/A
EPS(TTM)-5.46
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-43.99
FCFYN/A
OCF(TTM)-2.78
OCFYN/A
SpS0.56
BVpS82.31
TBVpS82.31
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4%
ROE -6.42%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-2.28%
ROA(5y)N/A
ROE(3y)-2.58%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 4363.3%
Cap/Sales 7387.57%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.75
Quick Ratio 0.75
Altman-Z N/A
F-Score1
WACC8.82%
ROIC/WACCN/A
Cap/Depr(3y)7464.22%
Cap/Depr(5y)N/A
Cap/Sales(3y)5751.01%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-49.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-107.36%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.92%
Revenue growth 3Y181.54%
Revenue growth 5YN/A
Sales Q2Q%83.76%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-17.71%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-2338.79%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-53.93%
OCF growth 3YN/A
OCF growth 5YN/A